1999
DOI: 10.1046/j.1432-1327.1999.00576.x
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of a novel cdk1‐related kinase

Abstract: The p13 suc1 /p9 CKShs proteins bind tightly to the cyclin-dependent kinases cdk1 and cdk2. The distantly related protein, p15 cdk-BP , binds cdk4/6, cdk5 and cdk8. We now show that immobilized p15 cdk-BP binds both an HMG-I kinase and a 35-kDa protein that cross-reacts with anti-PSTAIRE antibodies (PSTAIRE is a totally conserved motif located in subdomain III of cdk). This`cdkX' and the HMG-I kinase also bind to an immobilized inhibitor of cdks (HD). Several properties clearly distinguish cdkX, and its associ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2001
2001
2003
2003

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 59 publications
0
2
0
Order By: Relevance
“…Since a monoclonal anti-cdk3 was not available, we used monoclonal anti-PSTAIRE to verify that the anti-cdk3 immunoprecipitates contained a 36-kDa cdk protein. The PSTAIRE sequence is conserved among cdks and distinguishes them from other protein kinases [Morgan, 1997;Tournier et al, 1997;Detivaud et al, 1999]. Anti-PSTAIRE antibody revealed four prominent bands in immunoblots of whole cell extracts (Fig.…”
Section: Anti-cdk3 Immunoprecipitates a Roscovitine-mentioning
confidence: 96%
“…Since a monoclonal anti-cdk3 was not available, we used monoclonal anti-PSTAIRE to verify that the anti-cdk3 immunoprecipitates contained a 36-kDa cdk protein. The PSTAIRE sequence is conserved among cdks and distinguishes them from other protein kinases [Morgan, 1997;Tournier et al, 1997;Detivaud et al, 1999]. Anti-PSTAIRE antibody revealed four prominent bands in immunoblots of whole cell extracts (Fig.…”
Section: Anti-cdk3 Immunoprecipitates a Roscovitine-mentioning
confidence: 96%
“…Besides, cdk sensitive to this inhibitor may not be all known, and new cdkrelated enzymes are still being discovered. 31 Further development of cdk-specific inhibitors active in living cells will help to resolve this question and identify more precisely the functions of cdk in the different cellular processes.…”
Section: Potential Of Purvalanol a In Anticancer Therapy Concerns Itsmentioning
confidence: 99%